News
Home > News > News
- 2025/02/20The company accomplished Tacolimus audit, a client from Germany
- 2025/01/14The company accomplished Rapamycin audit, a client from Japan
- 2025/01/10The company accomplished Everolimus audit, a client from US
- 2024/11/28The company obtained US patent: PREPARATION METHOD OF TRILACICLIB
- 2024/11/22The company accomplished CCSBpofungin & Tacrolimus audit.
- 2024/10/31The company accomplished Tacrolimus audit.
- 2024/10/23The company accomplished Trandolapril audit.
- 2024/09/12The company accomplished Methocarbamol remote audit.
- 2024/08/29CCSB accomplished Rapamycin audit.
- 2024/05/17CCSB accomplished Mycophenolate Mofetil audit.
